{
    "nctId": "NCT00123799",
    "briefTitle": "Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection",
    "officialTitle": "A Phase II Study of Fluorodeoxyglucose (FluGlucoScan) in Patients With Breast Cancer: Correlation With Histologic Findings of Sentinel Node Biopsies and Axillary Dissection",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 199,
    "primaryOutcomeMeasure": "to determine whether preoperative PET imaging combined with sentinel node biopsy can accurately identify axillary node status",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or female. If female of child bearing potential and outside of the window of 10 days since the last menstrual period, a negative pregnancy test.\n* Biopsy proven breast carcinoma (core biopsy or fine needle aspiration, although core biopsies are preferred.)\n* Tumour size T1-3, N0 clinically\n* All patients will have pre-operative mammography +/- ultrasound of the breast\n* Age equal to or greater than 18 years\n* Able and willing to follow instructions and comply with the protocol\n* Provide written informed consent prior to participation in this study\n\nExclusion Criteria:\n\n* Nursing or pregnant females\n* Previous malignancy or diagnosis less than 10 (ten) years ago. Skin cancers (excluding malignant melanoma) and carcinoma in situ of the cervix are exceptions.\n* Excisional biopsy of the tumour has been performed\n* Age less than 18 years\n* Patient has diabetes",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}